Company profile: Medfield Diagnostics
1.1 - Company Overview
Company description
- Provider of microwave-based medical devices and diagnostics, including the Medfield Strokefinder MD100 for assisting clinical evaluation and triage of suspected intracranial injuries in acute situations. Develops systems for screening brain injuries in prehospital and hospital settings and researches future microwave imaging applications beyond brain injuries.
Products and services
- Prehospital screening technology: Microwave-based system that rapidly screens patients with suspected brain injuries, including stroke or trauma, to facilitate swift, appropriate care in pre-hospital environments
- Medfield Strokefinder MD100: Acute-care device that uses microwave technology to assist clinical evaluation and triage of suspected intracranial injuries in acute situations, supporting rapid decision-making in emergencies
- Microwave based medical device development: Hospital-grade engineering of systems using microwave technology for screening brain injuries in pre-hospital and hospital settings, advancing commercialization of research from Chalmers University of Technology
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Medfield Diagnostics
VistaGen Therapeutics
HQ: United States
Website
- Description: Provider of investigational biopharmaceutical therapies for CNS diseases and disorders: Fasedienol (for multiple anxiety disorders), Itruvone (for major depressive disorder and other depression-related conditions), PH80 (menopausal hot flashes, premenstrual dysphoric disorder, migraines), PH15 (to improve cognition), PH284 (appetite-related disorders, including Cachexia), AV-101 (oral prodrug targeting the NMDA receptor glycine site).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full VistaGen Therapeutics company profile →
Sooma Medical
HQ: Finland
Website
- Description: Provider of non-invasive tDCS-based brain stimulation therapies and devices for depression and chronic pain. Offers Sooma Duo, integrating a tDCS device with a digital platform for remote patient guidance and clinical management; Sooma Depression Therapy for MDD; Sooma Pain Therapy for fibromyalgia and chronic neuropathic pain; and a portable tDCS device with accessories and an online platform.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Sooma Medical company profile →
Trevena
HQ: United States
Website
- Description: Provider of an approved intravenous opioid analgesic (OLINVYK) for the management of acute pain in adults when alternative treatments are inadequate, and developer of GPCR-biased ligands, including TRV045 (oral S1P receptor; diabetic neuropathic pain and epilepsy; Phase 1), TRV250 (delta receptor; acute migraine; Phase 1), and TRV734 (oral mu receptor; maintenance treatment of opioid use disorder; Phase 1).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Trevena company profile →
Concert Pharmaceuticals
HQ: United States
Website
- Description: Provider of clinical-stage biotechnology developing drug products via a novel precision deuterium chemistry platform, modifying specific properties of validated drug molecules to create new medicines that address patient needs, yielding a rich pipeline.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Concert Pharmaceuticals company profile →
Pulsar Vascular
HQ: United States
Website
- Description: Provider of an endovascular platform addressing bifurcation aneurysms, offering the PulseRider Neck Reconstruction Device, a neck-bridge solution designed to span the aneurysm neck and support and stabilize an embolic coil mass.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Pulsar Vascular company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Medfield Diagnostics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Medfield Diagnostics
2.2 - Growth funds investing in similar companies to Medfield Diagnostics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Medfield Diagnostics
4.2 - Public trading comparable groups for Medfield Diagnostics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →